Publication | Closed Access

Short-term variations in bone remodeling markers of an oral contraception formulation containing 3 mg of drospirenone plus 30 μg of ethinyl estradiol: Observational study in young postadolescent women

ContraceptionHormonal ContraceptiveShort-term VariationsOvarian AgingOral ContraceptiveMedicineOral Contraception FormulationReproductive HealthGynecologyMenopauseFemale Reproductive FunctionEthinyl EstradiolPublic HealthEndocrinologyPharmacologyOsteoporosisWomen's Health